JP2005500305A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005500305A5 JP2005500305A5 JP2003506619A JP2003506619A JP2005500305A5 JP 2005500305 A5 JP2005500305 A5 JP 2005500305A5 JP 2003506619 A JP2003506619 A JP 2003506619A JP 2003506619 A JP2003506619 A JP 2003506619A JP 2005500305 A5 JP2005500305 A5 JP 2005500305A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- group
- compound
- phosphocholine
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000002193 Pain Diseases 0.000 claims 13
- 150000001875 compounds Chemical class 0.000 claims 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 6
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims 6
- 229930195729 fatty acid Natural products 0.000 claims 6
- 239000000194 fatty acid Substances 0.000 claims 6
- 150000004665 fatty acids Chemical class 0.000 claims 6
- 229920006395 saturated elastomer Polymers 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- WRGQSWVCFNIUNZ-GDCKJWNLSA-N 1-oleoyl-sn-glycerol 3-phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)(O)=O WRGQSWVCFNIUNZ-GDCKJWNLSA-N 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 239000001257 hydrogen Substances 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims 2
- -1 1-O-stearoyl-2-heptylnonyl-sn-glycero-3-phosphocholine Chemical compound 0.000 claims 2
- YWOIMIFPWICXIL-UHFFFAOYSA-N CCCCCCCC(OP(O)(O)=O)CCCCCCC Chemical compound CCCCCCCC(OP(O)(O)=O)CCCCCCC YWOIMIFPWICXIL-UHFFFAOYSA-N 0.000 claims 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 2
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- CWRILEGKIAOYKP-SSDOTTSWSA-M [(2r)-3-acetyloxy-2-hydroxypropyl] 2-aminoethyl phosphate Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCCN CWRILEGKIAOYKP-SSDOTTSWSA-M 0.000 claims 2
- SVKLKYBUMKNAGI-UHFFFAOYSA-N [3-heptyl-1-(trimethylazaniumyl)decan-2-yl] hydrogen phosphate Chemical compound CCCCCCCC(C(C[N+](C)(C)C)OP(O)([O-])=O)CCCCCCC SVKLKYBUMKNAGI-UHFFFAOYSA-N 0.000 claims 2
- 208000005298 acute pain Diseases 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 2
- 239000000460 chlorine Chemical group 0.000 claims 2
- 229910052801 chlorine Chemical group 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 150000002632 lipids Chemical class 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 208000004296 neuralgia Diseases 0.000 claims 2
- 208000021722 neuropathic pain Diseases 0.000 claims 2
- 230000001575 pathological effect Effects 0.000 claims 2
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 claims 2
- 150000003408 sphingolipids Chemical class 0.000 claims 2
- 206010044652 trigeminal neuralgia Diseases 0.000 claims 2
- QMTHILFALDMACK-UHFFFAOYSA-N 2-heptyl-nonanoic acid Chemical compound CCCCCCCC(C(O)=O)CCCCCCC QMTHILFALDMACK-UHFFFAOYSA-N 0.000 claims 1
- PLVOWOHSFJLXOR-UHFFFAOYSA-N 2-pentylheptanoic acid Chemical compound CCCCCC(C(O)=O)CCCCC PLVOWOHSFJLXOR-UHFFFAOYSA-N 0.000 claims 1
- NJUGDERYCCDBMJ-UHFFFAOYSA-N 2-propyldodecanoic acid Chemical compound CCCCCCCCCCC(C(O)=O)CCC NJUGDERYCCDBMJ-UHFFFAOYSA-N 0.000 claims 1
- TVBCCWGVCZSXFD-UHFFFAOYSA-N 4-amino-3-butyl-1h-1,2,4-triazole-5-thione Chemical compound CCCCC1=NNC(=S)N1N TVBCCWGVCZSXFD-UHFFFAOYSA-N 0.000 claims 1
- IYAWWERFNQBGCN-PGXONZMJSA-N CCCCCCCCCCCCCCCCCC(OC[C@H](COP([O-])(OC(C[N+](C)(C)C)C(C(CCC)CCCCCCCCCC)=O)=O)O)=O Chemical compound CCCCCCCCCCCCCCCCCC(OC[C@H](COP([O-])(OC(C[N+](C)(C)C)C(C(CCC)CCCCCCCCCC)=O)=O)O)=O IYAWWERFNQBGCN-PGXONZMJSA-N 0.000 claims 1
- 208000000094 Chronic Pain Diseases 0.000 claims 1
- 208000016192 Demyelinating disease Diseases 0.000 claims 1
- 206010012305 Demyelination Diseases 0.000 claims 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 claims 1
- 208000031886 HIV Infections Diseases 0.000 claims 1
- 208000037357 HIV infectious disease Diseases 0.000 claims 1
- 206010019233 Headaches Diseases 0.000 claims 1
- 208000031220 Hemophilia Diseases 0.000 claims 1
- 208000009292 Hemophilia A Diseases 0.000 claims 1
- 208000007514 Herpes zoster Diseases 0.000 claims 1
- 208000007914 Labor Pain Diseases 0.000 claims 1
- 208000035945 Labour pain Diseases 0.000 claims 1
- 208000000112 Myalgia Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 206010029174 Nerve compression Diseases 0.000 claims 1
- 208000010886 Peripheral nerve injury Diseases 0.000 claims 1
- 206010036376 Postherpetic Neuralgia Diseases 0.000 claims 1
- 208000004550 Postoperative Pain Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 238000002266 amputation Methods 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 231100000869 headache Toxicity 0.000 claims 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 1
- 230000004968 inflammatory condition Effects 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 208000013465 muscle pain Diseases 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- JZYNIDGYXBCHCG-UHFFFAOYSA-N pentadecan-8-yl 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCC(CCCCCCC)OP([O-])(=O)OCC[N+](C)(C)C JZYNIDGYXBCHCG-UHFFFAOYSA-N 0.000 claims 1
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 claims 1
- 150000003904 phospholipids Chemical class 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 208000007056 sickle cell anemia Diseases 0.000 claims 1
- 208000020431 spinal cord injury Diseases 0.000 claims 1
- 208000004371 toothache Diseases 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/888,958 US6518311B2 (en) | 1997-07-09 | 2001-06-25 | Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| PCT/IL2002/000502 WO2003000173A2 (en) | 2001-06-25 | 2002-06-24 | Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005500305A JP2005500305A (ja) | 2005-01-06 |
| JP2005500305A5 true JP2005500305A5 (cg-RX-API-DMAC7.html) | 2005-12-22 |
| JP4272052B2 JP4272052B2 (ja) | 2009-06-03 |
Family
ID=25394247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003506619A Expired - Lifetime JP4272052B2 (ja) | 2001-06-25 | 2002-06-24 | 分枝鎖状脂肪酸およびその誘導体の痛み処置における使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6518311B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1419129B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4272052B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE415965T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2002314503C1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2450946C (cg-RX-API-DMAC7.html) |
| DE (1) | DE60230155D1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL159241A0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003000173A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6518311B2 (en) * | 1997-07-09 | 2003-02-11 | D-Pharm Ltd. | Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| US7582678B2 (en) * | 1997-07-09 | 2009-09-01 | D-Pharm Limited | Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| EP1485107A1 (en) | 2002-02-11 | 2004-12-15 | Vertex Pharmaceuticals Incorporated | Phospholipids as caspase inhibitor prodrugs |
| US20040265364A1 (en) * | 2003-06-25 | 2004-12-30 | Binnur Ozturk | Neuropathy cream |
| US20050095277A1 (en) * | 2003-06-25 | 2005-05-05 | Binnur Ozturk | Neuropathy cream |
| DE10332486A1 (de) * | 2003-07-16 | 2005-02-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol für die Behandlung akuter Schmerzen |
| EP2465499A3 (en) * | 2005-06-27 | 2013-02-13 | Ono Pharmaceutical Co., Ltd. | Therapeutic agent for treating pain |
| JP4587961B2 (ja) * | 2006-01-16 | 2010-11-24 | 独立行政法人科学技術振興機構 | 神経因性疼痛治療剤 |
| CN101801200B (zh) | 2007-09-17 | 2014-10-29 | 康奈尔大学 | 用于预防或治疗胃肠病症的支链脂肪酸 |
| EP2381940A4 (en) * | 2008-11-26 | 2012-12-05 | Univ Texas | NOVEL FAMILY OF PAIN PRODUCING SUBSTANCES AND METHODS OF PRODUCING NEW ANALGESIC MEDICINES |
| GB0910781D0 (en) | 2009-06-23 | 2009-08-05 | Croda Int Plc | Slip and antiblocking agent |
| WO2012105477A1 (ja) * | 2011-01-31 | 2012-08-09 | 日本臓器製薬株式会社 | 鎮痛剤 |
| US9029342B2 (en) | 2012-09-17 | 2015-05-12 | Board Of Regents Of The University Of Texas System | Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0625090B2 (ja) | 1987-02-12 | 1994-04-06 | 花王株式会社 | 毛髪化粧料 |
| CA2059272A1 (en) | 1990-04-12 | 1991-10-13 | Akira Hasegawa | 4,6-0-hydroxyphosphoryl-glucosamine derivatives |
| EP0632008B1 (en) | 1993-06-01 | 1998-02-04 | Ono Pharmaceutical Co., Ltd. | Pentanoic acid derivatives |
| US6313106B1 (en) * | 1995-06-07 | 2001-11-06 | D-Pharm Ltd. | Phospholipid derivatives of valproic acid and mixtures thereof |
| IL121268A0 (en) * | 1997-07-09 | 1998-01-04 | Dpharm Ltd | Branched chain fatty acids their derivatives and use in the treatment of central nervous system disorders |
| US6518311B2 (en) * | 1997-07-09 | 2003-02-11 | D-Pharm Ltd. | Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| IL137672A0 (en) * | 2000-08-03 | 2001-10-31 | Dpharm Ltd | Derivatives of branched-chain lipophilic molecules and uses thereof |
-
2001
- 2001-06-25 US US09/888,958 patent/US6518311B2/en not_active Expired - Fee Related
-
2002
- 2002-06-24 JP JP2003506619A patent/JP4272052B2/ja not_active Expired - Lifetime
- 2002-06-24 CA CA2450946A patent/CA2450946C/en not_active Expired - Fee Related
- 2002-06-24 DE DE60230155T patent/DE60230155D1/de not_active Expired - Lifetime
- 2002-06-24 IL IL15924102A patent/IL159241A0/xx active IP Right Grant
- 2002-06-24 EP EP02741140A patent/EP1419129B1/en not_active Expired - Lifetime
- 2002-06-24 AT AT02741140T patent/ATE415965T1/de not_active IP Right Cessation
- 2002-06-24 WO PCT/IL2002/000502 patent/WO2003000173A2/en not_active Ceased
- 2002-06-24 AU AU2002314503A patent/AU2002314503C1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6355629B2 (en) | Prodrugs with enhanced penetration into cells | |
| CN1191826C (zh) | 药物制剂 | |
| SE451427B (sv) | Parenteralt administrerbara vattenlosningar med ett fysiologiskt ph och sett att framstella dessa losningar | |
| ES2640474T3 (es) | Compuestos lipoílicos y su uso para el tratamiento de la lesión isquémica | |
| IL186169A (en) | Charged lipoprotein complexes, pharmaceutical compositions comprising them and their uses | |
| JP2018518537A5 (cg-RX-API-DMAC7.html) | ||
| US6489312B1 (en) | Pharmaceutical formulations comprising aminoalkyl phosphorothioates | |
| US11312737B2 (en) | Amide-linked EP4 agonist-bisphosphonate compounds and uses thereof | |
| JP2010526827A5 (cg-RX-API-DMAC7.html) | ||
| CA2450946A1 (en) | Use of branched-chain fatty acids and derivatives thereof for the treatment of pain | |
| JP2001509500A (ja) | 分岐鎖脂肪酸、それらの誘導体、および中枢神経系障害の処置における使用 | |
| JP2010509204A5 (cg-RX-API-DMAC7.html) | ||
| JP2014533264A (ja) | 三環式化合物、それらを含む組成物およびそれらの使用 | |
| JP2004509854A5 (cg-RX-API-DMAC7.html) | ||
| ES2529724T3 (es) | Tratamiento de enfermedades autoinmunes | |
| JP2023517919A5 (cg-RX-API-DMAC7.html) | ||
| JP2021521210A5 (cg-RX-API-DMAC7.html) | ||
| RU2013130027A (ru) | Новые оксимовые производные в качестве модуляторов рецептора сфингозин 1-фосфата (s1p) | |
| JP2006522834A5 (cg-RX-API-DMAC7.html) | ||
| WO2019143743A1 (en) | Methods and agents that enhance myogenic progenitor cell engraftment | |
| EP2175862B1 (en) | Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds | |
| JP2006510733A (ja) | カルジオリピン分子および合成方法 | |
| US20220242893A1 (en) | Amide-linked conjugate compounds and uses thereof | |
| JP2023513086A (ja) | 炎症性疾患を処置するための胆汁酸-gcpii阻害剤コンジュゲート | |
| CN104321323B (zh) | 碳环核苷及其医药用途和组合物 |